Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Potential for ondansetron is in supportive care to cancer patients (CINV and RINV) and post anesthesia (PONV)

February 19, 2009

Analysis of:BioAlliance seeks European marketing nod for ondansetron RapidFilm | www.pharmabiz.com

Potential for ondansetron Rapid Film is based on increased convenience for the patients suffering from CINV and RINV There is also an opportunity with PONV

Risk of linking funding, precaution principle and marketing techniques

December 8, 2008

Analysis of:Drug Marketing Techniques May Be Risking Patient Safety | pharmalive.com

Marketing techniques vary depending on the type of product: hospital or specialty care products need to be advertised soon and fast to the patient audience so as to increase the access to novel techniques, usually well documented and reserved to targeted patients. The Authorities apply the "precaution principle" and this is in the best interest of patients. Recent failures include predominantly primary care products, pushed forward with large pharma companies using a disproportionate investment. Such failures include Merck's Vioxx, Bayer's cerivastatine, Sanofi's Acomplia, etc The funding of Authorities by pharma companies should not be an issue as soon as the techniques and criteria used in the Health Technology Evaluations are made public and applied consistently.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS